As described above, nepmucin expression was also decreased in the ECs of tumors and tumor-draining LNs, leading us to speculate that tumors secrete certain soluble factors that negatively regulate nepmucin expression, and that these tumor-derived factors are transported to the draining LNs via lymph. This evidence concerns the gene CD300LG and neoplasm.